IMPACT OF HYDROGEN SULFIDE ON OUTCOME OF CARDIAC ARREST AND CARDIOPULMONARY RESUS
硫化氢对心脏骤停和心肺复苏结果的影响
基本信息
- 批准号:8236893
- 负责人:
- 金额:$ 42.89万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-04-05 至 2015-03-31
- 项目状态:已结题
- 来源:
- 关键词:AddressAnimal ModelAnimalsAttenuatedBasic ScienceBiologicalBrainBrain InjuriesBrain regionBreathingCardiacCardiac MyocytesCardiopulmonaryCardiopulmonary ResuscitationCaringCause of DeathCerebral EdemaCessation of lifeCharacteristicsClinicalClinical ResearchDefibrillatorsDevelopmentDiffusionEndothelial CellsEvolutionExhibitsFailureFamily suidaeFunctional disorderGasesGoalsHeart ArrestHydrogen SulfideImaging TechniquesInflammationInjuryInterdisciplinary StudyLifeMagnetic Resonance ImagingMethodsModelingMolecularMusMyocardialMyocardial IschemiaMyocardial dysfunctionNervous System PhysiologyNeurologic DysfunctionsNeurological outcomeNeuronsNitric OxideOdorsOutcomeOxidative StressProductionRadiology SpecialtyReperfusion InjuryReportingResearchRodentRoleSignal TransductionSourceStructureStudy SectionSulfidesSyndromeTechniquesTestingTherapeuticTimeTranslatingTranslational ResearchTraumaWeightbasebioimagingcytotoxicegghuman NOS3 proteinimaging modalityimprovedin vivo Modelinnovationmouse modelmultidisciplinarynatural hypothermianovelnovel strategiesnovel therapeuticspre-clinicalpreventprotective effectpublic health relevanceresearch studyresponsesodium sulfidewater diffusion
项目摘要
DESCRIPTION (provided by applicant): Sudden cardiac arrest (CA) is one of the leading causes of death worldwide. Despite advances in cardiopulmonary resuscitation (CPR) methods, 60-80% of these arrests result in immediate death, and of the remaining, only about 5 percent are successfully resuscitated to the extent that they are returned to productive lives. Innovative approach is needed to improve the outcome of cardiac arrest and CPR. Hydrogen sulfide is a colorless gas with a characteristic rotten-egg odor found in various natural and industrial sources. Recent studies suggested that H2S is endogenously produced and exerts a host of biological effects on various targets, resulting in responses that range from cytotoxic to cytoprotective effects. It has been reported that administration of an H2S donor (Na2S) attenuates myocardial ischemia-reperfusion (IR) injury in rodents and pig. In studies presented in the Preliminary Studies section, we observed that administration of Na2S at the time of CPR markedly improved myocardial and neurological function and survival 24h after CA/CPR in mice. The robust protective effect of Na2S was associated with attenuated oxidative stress, neuronal death, and enhanced NO signal. Of note, the protective effects of Na2S were abolished by NOS3 deficiency. Importantly, administration of Na2S prevented CA/CPR-induced development of marked cerebral edema 24h after CA/CPR as demonstrated by diffusion-weighted MRI in live mice. The overall goal of this proposal is to elucidate the role of H2S and develop novel therapeutic strategies to improve outcomes of CA/CPR complicated with post-cardiac arrest syndrome. Specifically, we propose: (Aim 1) To characterize time-dependent evolution of neurological and myocardial dysfunction and systemic inflammation in a mouse model of CA/CPR with optimized post-cardiac arrest care, (Aim 2) To define the impact of hydrogen sulfide on the evolution of neurological and myocardial dysfunction after CA/CPR, (Aim 3) To define the role of NOS for the protective effects of H2S on outcome of CA/CPR, and (Aim 4) To elucidate the molecular signaling mechanisms responsible for the protective effects of hydrogen sulfide in cultured neurons, endothelial cells, and cardiomyocytes. We anticipate that proposed studies will illuminate the unique protective effects of sulfide-based approach to CA/CPR using our innovative in vivo model of murine cardiac arrest and CPR.
PUBLIC HEALTH RELEVANCE: Sudden cardiac arrest (CA) is one of the leading causes of death worldwide. Despite advances in cardiopulmonary resuscitation (CPR) methods, 60-80% of these arrests result in immediate death, and of the remaining, only about 5 percent are successfully resuscitated to the extent that they are returned to productive lives. Innovative approach is needed to improve the outcome of cardiac arrest and CPR. The overall goal of this proposal is to elucidate the role of H2S and develop novel therapeutic strategies to improve outcomes of CA/CPR complicated with post-cardiac arrest syndrome. We anticipate that proposed studies will illuminate the unique protective effects of sulfide-based approach to CA/CPR using our innovative in vivo model of murine cardiac arrest and CPR.
描述(由申请人提供):心脏骤停(CA)是全世界死亡的主要原因之一。尽管心肺复苏 (CPR) 方法取得了进步,但 60-80% 的逮捕会导致立即死亡,而在其余的人中,只有约 5% 能够成功复苏并恢复正常生活。需要创新方法来改善心脏骤停和心肺复苏的结果。 硫化氢是一种无色气体,具有典型的臭鸡蛋气味,存在于各种天然和工业来源中。最近的研究表明,H2S 是内源产生的,并对各种靶标产生多种生物效应,产生从细胞毒性到细胞保护作用的反应。据报道,给予 H2S 供体 (Na2S) 可减轻啮齿动物和猪的心肌缺血再灌注 (IR) 损伤。在“初步研究”部分中介绍的研究中,我们观察到在 CPR 时给予 Na2S 可显着改善小鼠 CA/CPR 后 24 小时的心肌和神经功能以及存活率。 Na2S 的强大保护作用与氧化应激减弱、神经元死亡和 NO 信号增强有关。值得注意的是,Na2S 的保护作用因 NOS3 缺乏而消失。重要的是,在活体小鼠中进行弥散加权 MRI 证实,在 CA/CPR 24 小时后,施用 Na2S 可以防止 CA/CPR 诱导的明显脑水肿的发展。 该提案的总体目标是阐明 H2S 的作用并开发新的治疗策略,以改善 CA/CPR 并发心脏骤停后综合征的结果。具体来说,我们建议:(目标 1)通过优化的心脏骤停后护理来表征 CA/CPR 小鼠模型中神经和心肌功能障碍以及全身炎症的时间依赖性演变,(目标 2)确定硫化氢的影响CA/CPR 后神经和心肌功能障碍的演变,(目标 3)确定 NOS 在 H2S 对 CA/CPR 结局的保护作用中的作用,以及(目标 4)阐明负责硫化氢对培养的神经元、内皮细胞和心肌细胞的保护作用的分子信号机制。 我们预计,拟议的研究将利用我们创新的小鼠心脏骤停和心肺复苏体内模型,阐明基于硫化物的方法对 CA/CPR 的独特保护作用。
公共卫生相关性:心脏骤停 (CA) 是全世界死亡的主要原因之一。尽管心肺复苏 (CPR) 方法取得了进步,但 60-80% 的逮捕会导致立即死亡,而在其余的人中,只有约 5% 能够成功复苏并恢复正常生活。需要创新方法来改善心脏骤停和心肺复苏的结果。该提案的总体目标是阐明 H2S 的作用并开发新的治疗策略,以改善 CA/CPR 并发心脏骤停后综合征的结果。我们预计,拟议的研究将利用我们创新的小鼠心脏骤停和心肺复苏体内模型,阐明基于硫化物的方法对 CA/CPR 的独特保护作用。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
FUMITO ICHINOSE其他文献
FUMITO ICHINOSE的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('FUMITO ICHINOSE', 18)}}的其他基金
Role of Sedation in the Post-Cardiac Arrest Neurological Recovery
镇静在心脏骤停后神经恢复中的作用
- 批准号:
10735115 - 财政年份:2023
- 资助金额:
$ 42.89万 - 项目类别:
Role of sulfide catabolism in ischemic brain injury
硫化物分解代谢在缺血性脑损伤中的作用
- 批准号:
10378758 - 财政年份:2019
- 资助金额:
$ 42.89万 - 项目类别:
Role of sulfide catabolism in ischemic brain injury
硫化物分解代谢在缺血性脑损伤中的作用
- 批准号:
10588192 - 财政年份:2019
- 资助金额:
$ 42.89万 - 项目类别:
IMPACT OF HYDROGEN SULFIDE ON OUTCOME OF CARDIAC ARREST AND CARDIOPULMONARY RESUS
硫化氢对心脏骤停和心肺复苏结果的影响
- 批准号:
8463026 - 财政年份:2010
- 资助金额:
$ 42.89万 - 项目类别:
IMPACT OF HYDROGEN SULFIDE ON OUTCOME OF CARDIAC ARREST AND CARDIOPULMONARY RESUS
硫化氢对心脏骤停和心肺复苏结果的影响
- 批准号:
8055816 - 财政年份:2010
- 资助金额:
$ 42.89万 - 项目类别:
IMPACT OF HYDROGEN SULFIDE ON OUTCOME OF CARDIAC ARREST AND CARDIOPULMONARY RESUS
硫化氢对心脏骤停和心肺复苏结果的影响
- 批准号:
8645697 - 财政年份:2010
- 资助金额:
$ 42.89万 - 项目类别:
IMPACT OF HYDROGEN SULFIDE ON OUTCOME OF CARDIAC ARREST AND CARDIOPULMONARY RESUS
硫化氢对心脏骤停和心肺复苏结果的影响
- 批准号:
7862033 - 财政年份:2010
- 资助金额:
$ 42.89万 - 项目类别:
Impact of nitric oxide synthase on myocardial dysfunction of sepsis
一氧化氮合酶对脓毒症心肌功能障碍的影响
- 批准号:
7805407 - 财政年份:2007
- 资助金额:
$ 42.89万 - 项目类别:
Impact of nitric oxide synthase on myocardial dysfunction of sepsis
一氧化氮合酶对脓毒症心肌功能障碍的影响
- 批准号:
7186477 - 财政年份:2007
- 资助金额:
$ 42.89万 - 项目类别:
Impact of nitric oxide synthase on myocardial dysfunction of sepsis
一氧化氮合酶对脓毒症心肌功能障碍的影响
- 批准号:
7618495 - 财政年份:2007
- 资助金额:
$ 42.89万 - 项目类别:
相似国自然基金
髋关节撞击综合征过度运动及机械刺激动物模型建立与相关致病机制研究
- 批准号:82372496
- 批准年份:2023
- 资助金额:48 万元
- 项目类别:面上项目
探索在急性呼吸窘迫综合征动物模型和患者长时间俯卧位通气过程中动态滴定呼气末正压的意义
- 批准号:82270081
- 批准年份:2022
- 资助金额:76 万元
- 项目类别:面上项目
雌激素抑制髓系白血病动物模型中粒细胞异常增生的机制
- 批准号:
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
基于中医经典名方干预效应差异的非酒精性脂肪性肝病动物模型证候判别研究
- 批准号:
- 批准年份:2022
- 资助金额:53 万元
- 项目类别:面上项目
无菌动物模型与单细胞拉曼技术结合的猴与人自闭症靶标菌筛选及其机制研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Effects of tACS on alcohol-induced cognitive and neurochemical deficits
tACS 对酒精引起的认知和神经化学缺陷的影响
- 批准号:
10825849 - 财政年份:2024
- 资助金额:
$ 42.89万 - 项目类别:
Chronic Pain and Risk of Alzheimer's-Related Neurodegeneration
慢性疼痛和阿尔茨海默病相关神经变性的风险
- 批准号:
10644253 - 财政年份:2023
- 资助金额:
$ 42.89万 - 项目类别:
An Integrated Catheter Dressing for Early Detection of Catheter-related Bloodstream Infections
用于早期检测导管相关血流感染的集成导管敷料
- 批准号:
10647072 - 财政年份:2023
- 资助金额:
$ 42.89万 - 项目类别:
Postnatal and Prenatal Therapeutic Base Editing for Metabolic Diseases
代谢性疾病的产后和产前治疗碱基编辑
- 批准号:
10668614 - 财政年份:2023
- 资助金额:
$ 42.89万 - 项目类别: